Entero Therapeutics, Inc. Common Stock (ENTO) Free Cash Flow (2024 - 2025)
Entero Therapeutics, Inc. Common Stock (ENTO) free cash flow from Jun 30, 2024 to Sep 30, 2025. The TTM Entero Therapeutics, Inc. Common Stock (ENTO) free cash flow is -$1.90M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Entero Therapeutics, Inc. Common Stock (ENTO) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -64.15% |
Annual Free Cash Flow change of Entero Therapeutics, Inc. Common Stock (ENTO)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$1.73M | -81.24% |
| 2024 | -$9.22M | N/A |